White label – Pompe disease - ClinicalTrials.eu

A Study of INCB123667 in Patients With Platinum-Resistant Ovarian Cancer That Has High Levels of Cyclin E1 Protein

Recruiting

2 1 1
Investigated Diseases:
- Ovarian cancer
Investigated Drugs:
- INCB123667
A Study of Sacituzumab Tirumotecan, Pembrolizumab, and Bevacizumab for Patients with Metastatic Cervical Cancer That Has Spread or Returned

Recruiting

3 1 1 1
Investigated Diseases:
- Cervix carcinoma
Investigated Drugs:
+7
Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

Recruiting

3 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- ICOTROKINRA
+7
Study of icotrokinra for adults with moderately to severely active Crohn’s disease

Recruiting

4 1
Investigated Diseases:
- Crohn’s disease
Investigated Drugs:
- ICOTROKINRA
+7
A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- AZD3632
Comparing irinotecan plus cetuximab with trifluridine and tipiracil plus bevacizumab for patients with metastatic colorectal cancer as third line treatment

Recruiting

2 1 1 1
Investigated Diseases:
- Colorectal cancer metastatic
Investigated Drugs:
A study testing gene therapy with Dream01 and imatinib for patients with severe sickle cell disease to improve red blood cell production

Recruiting

2 1 1 1
Investigated Drugs:
- Imatinib
Testing zongertinib compared to standard treatment in patients with early-stage non-small cell lung cancer with HER2 mutations after surgery

Recruiting

3 1 1 1
Investigated Drugs:
+6
A Study of Belumosudil for Patients with Steroid-Resistant Overlap Syndrome Graft-versus-Host Disease

Recruiting

2 1 1
Investigated Diseases:
- Chronic graft versus host disease
Investigated Drugs:
- Belumosudil Mesilate
Study of melphalan followed by eribulin, vinorelbine, or capecitabine versus eribulin, vinorelbine, or capecitabine alone for metastatic breast cancer patients with liver disease

Recruiting

2 1 1 1
Investigated Diseases:
- Breast cancer metastatic
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies